GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » NonCurrent Deferred Liabilities

PharmaCielo (TSXV:PCLO) NonCurrent Deferred Liabilities : C$0.00 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is PharmaCielo NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

PharmaCielo's non-current deferred liabilities for the quarter that ended in Sep. 2024 was C$0.00 Mil.

PharmaCielo NonCurrent Deferred Liabilities Historical Data

The historical data trend for PharmaCielo's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo NonCurrent Deferred Liabilities Chart

PharmaCielo Annual Data
Trend Aug17 Aug18 Dec19 Dec20 Dec21 Dec22 Dec23
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial - 0.49 0.36 - -

PharmaCielo Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaCielo NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of PharmaCielo's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaCielo Business Description

Industry
Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of its revenue in the form of the Sale of Cannabis derivative products in Colombia.
Executives
Ian D Atacan Director, Senior Officer
Marc Lustig Director
William Boris Petron Director
Henning Von Koss Director, Senior Officer
Anthony Wile 10% Security Holder

PharmaCielo Headlines